The RESI conference is poised to be one of the more unique events in the life sciences space this coming fall. This full-day investor partnering conference is groundbreaking in that it is focused on redefining the investor landscape in early stage life sciences. As all of us in the industry are aware, the life science investor landscape has changed; venture capital has left a void and there is a plethora of new entities entering the space with capital to allocate.
This conference has assembled these players – Senior decision-makers from some of the largest pharmaceutical & device companies, patient groups, philanthropic organizations, investment banks, and family offices will all be joining the action on September 16th. The conference will also have representation from next-generation technology transfer, licensing and funding experts, and there will be a free fund-raising boot camp. We urge all biotech and medtech readers to take a look at the program, and to take some time out to reeducate themselves regarding the new landscape unfolding in the life science investor arena.
Biohealth Innovation has been able to secure Earlybird pricing for our readership through August 30th via this link – We look forward to meeting you in September!